{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:24:51Z","timestamp":1776759891997,"version":"3.51.2"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:p>The goal of this study is exploring the disparity of incidence, mortality and survival outcome among transitional cell carcinomas (TCCs) in the 4 parts of urinary system. This study comprehensively evaluates these disparities using the Surveillance, Epidemiology, and End Results (SEER) (2000\u20132018) database. According to the SEER database, the urinary tract is divided into 4 parts: urinary bladder, renal pelvis, ureter, and urethra. The joinpoint regression was used to analyze the secular trend of incidence and incidence-based mortality (IBM). The Kaplan\u2013Meier method with the log-rank test is performed to evaluate survival outcomes. The bladder TCC has the highest age-adjusted incidence and mortality rate compared with TCC in other 3 locations. A slight decrease in incidence is shown in the both bladder and urethra TCCs during 2000\u20132018. The age-adjusted mortality rate similarly presents an initial increase among 4 locations TCCs at the beginning of study period. The survival curves demonstrate that patients with bladder TCCs have better overall survival (OS) and cancer-specific survival (CSS), whereas those with renal pelvis TCCs have the worse OS and CSS. In addition, patients with bladder TCC have the highest 1-year, 3-year, 5-year relative survival rate, and those with renal pelvis TCC have the lowest. These disparities are especially essential when we explore tumor characteristics and treatment, extrapolated from the literature on bladder TCC for upper tract urothelial carcinoma (UTUC). Notably, patients with bladder TCC especially for localized stage have better survival outcomes than those with UTUC.<\/jats:p>","DOI":"10.1097\/md.0000000000036063","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:26:58Z","timestamp":1701163618000},"page":"e36063","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Incidence, mortality and survival of transitional cell carcinoma in the urinary system: A population-based analysis"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiaofeng","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Hospital of Putian City, Putian, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-3705","authenticated-orcid":false,"given":"Xiangpeng","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Hospital of Putian City, Putian, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Putian University, Putian, Fujian, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines.","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update.","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update.","volume":"79","author":"Roupret","year":"2021","journal-title":"Eur Urol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2214\/ajr.155.4.2119098","article-title":"Transitional cell carcinoma of the pelvicalices and ureter.","volume":"155","author":"Leder","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins.","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"R7-20250504","first-page":"15","article-title":"Differences between upper tract urothelial carcinoma and bladder cancer.","volume":"26","author":"Singla","year":"2021","journal-title":"AUA news"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(20)30519-5","article-title":"Treatment of upper urinary tract urothelial carcinoma.","volume":"395","author":"Crabb","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","article-title":"A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer.","volume":"47","author":"Chu","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1002\/cncr.31638","article-title":"Trends in breast cancer mortality by stage at diagnosis among young women in the United States.","volume":"124","author":"Guo","year":"2018","journal-title":"Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0006-3223(98)00043-2","article-title":"Multiple correlations and Bonferroni\u2019s correction.","volume":"44","author":"Curtin","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bju.13760","article-title":"Guideline of guidelines: non-muscle-invasive bladder cancer.","volume":"119","author":"Woldu","year":"2017","journal-title":"BJU Int"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000472475","article-title":"Transitional cell carcinoma of the anterior urethra.","volume":"11","author":"Robles","year":"1985","journal-title":"Eur Urol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000471981","article-title":"Tumours of the upper urinary tract calyces, renal pelvis and ureter.","volume":"2","author":"Mazeman","year":"1976","journal-title":"Eur Urol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","article-title":"A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.","volume":"95","author":"Stewart","year":"2005","journal-title":"BJU Int"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"18797","DOI":"10.18632\/oncotarget.24694","article-title":"Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis.","volume":"9","author":"Goldberg","year":"2018","journal-title":"Oncotarget"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14020","article-title":"Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks.","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-019-5267-3","article-title":"Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.","volume":"19","author":"Al-Husseini","year":"2019","journal-title":"BMC Cancer"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends.","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0360-3016(03)00665-5","article-title":"Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.","volume":"57","author":"Fiorino","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018.","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-20250504","first-page":"E248","article-title":"The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery.","volume":"15","author":"Tam","year":"2021","journal-title":"Can Urol Assoc J"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.juro.2013.09.031","article-title":"Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?","volume":"191","author":"Krabbe","year":"2014","journal-title":"J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:03:56Z","timestamp":1746345836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":25,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036063","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}